...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues.
【24h】

Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues.

机译:新型不饱和无环和环氧化物核苷类似物的合成,X射线晶体结构研究,抗病毒和细胞抑制作用评估。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of the novel purine and pyrimidine nucleoside analogues were synthesised in which the sugar moiety was replaced by the 4-amino-2-butenyl (2-6 and 10-18) and oxiranyl (8 and 20) spacer. The Z- (2-6) and E-isomers (10-18) of unsaturated acyclic nucleoside analogues were synthesized by condensation of 2- and 6-substituted purine and 5-substituted uracil bases with Z- (1) or E-phthalimide (9) precursors. The oxiranyl nucleoside analogues (8 and 20) were obtained by epoxidation of 1 and 9 with m-chloroperoxybenzoic acid and subsequent coupling with adenine. The new compounds were evaluated for their antiviral and antitumor cell activities. Among the olefinic nucleoside analogues, Z-isomer of adenine containing 4-amino-2-butenyl side chain (6) exhibited the best cytostatic activities, particularly against colon carcinoma (SW 620, IC50 = 26 microM). Its E-isomer 15 did not show any antiproliferative activity against malignant tumor cell lines, except for a slight inhibition of colon carcinoma (SW 620, IC50 = 56.5 microM) cells. In general, Z-isomers showed better cytostatic activities than the corresponding E-isomers. (Z)-4-Amino-2-butenyl-adenine nucleoside analogue 6 showed albeit modest but selective activity against HIV-1 (EC50 = 4.83 microg mL(-1)).
机译:合成了一系列新颖的嘌呤和嘧啶核苷类似物,其中糖部分被4-氨基-2-丁烯基(2-6和10-18)和环氧乙烷基(8和20)间隔基取代。不饱和无环核苷类似物的Z-(2-6)和E-异构体(10-18)通过将2和6个取代的嘌呤和5个取代的尿嘧啶碱基与Z-(1)或E-邻苯二甲酰亚胺缩合而合成(9)前体。环氧乙烷基核苷类似物(8和20)是通过1和9与间氯过氧苯甲酸环氧化,然后与腺嘌呤偶联获得的。评价了新化合物的抗病毒和抗肿瘤细胞活性。在烯烃核苷类似物中,含有4-氨基-2-丁烯基侧链的腺嘌呤的Z-异构体(6)表现出最佳的细胞抑制活性,特别是对结肠癌的抑制作用(SW 620,IC50 = 26 microM)。它的E-异构体15除了对结肠癌(SW 620,IC50 = 56.5 microM)细胞有轻微抑制作用外,对恶性肿瘤细胞系没有任何抗增殖活性。通常,Z-异构体显示出比相应的E-异构体更好的细胞抑制活性。 (Z)-4-氨基-2-丁烯基-腺嘌呤核苷类似物6表现出适度但对HIV-1的选择性活性(EC50 = 4.83 microg mL(-1))。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号